Why Sorrento Therapeutic’s Antibody Breakthrough Is Huge
Sorrento Therapeutics shares jumped to start the week after the company announced that its COVID-19 antibody treatment had a positive showing.
Sorrento Therapeutics shares jumped to start the week after the company announced that its COVID-19 antibody treatment had a positive showing.
Walmart is set to report its most recent quarterly results before the opening bell on Tuesday, and analysts anticipate modest year-over-year growth.
Home Depot is scheduled to release its fiscal first-quarter financial results before the markets open on Tuesday, and analysts anticipate that per-share earnings will be about the same as a year ago.
Moderna made a big step towards a COVID-19 vaccine early on Monday, and investors (and the stock market in general) responded very positively.
Boeing’s CEO remains confident despite the toll the coronavirus has taken on the aerospace and travel industries.
24/7 Wall St. previews Home Depot, Target, Walmart and some of the other key companies reporting this coming week.
With the coronavirus shutdown boosting social media use and a move into online gaming, Facebook is well positioned to withstand declining ad demand.
Wedbush took a closer look at some of the companies in its coverage universe that are set to present at ASCO and what the impact may be going forward.
Applied Materials shares retreated early Friday after it reported disappointing second-quarter results and offered no guidance.
Amazon has earned its reputation as the "Death Star" but Jeff Bezos wants to sound less like Darth Vader.
Beyond Meat looks like the real deal to growth investors as the coronavirus changes consumer habits and China market beckons.
AIM ImmunoTech shares ticked higher on Thursday after the company announced some big developments with the FDA concerning its treatment for cancer patients with COVID-19.
Applied DNA Sciences shares made an incredible gain on Thursday after the company announced it had received an update from the FDA concerning its COVID-19 assay kit.
Networking giant Cisco reported third fiscal quarter earnings of $0.79 per share and $11.98 billion in revenue compared with consensus estimates that called for $0.71 in per-share earings and $11.88 billion in revenue.
There are still a lot of questions for Amarin must figure out before it gets back on track. For investors, the question is whether it is the market recovery that is lifting the stock…
Slumping iPhone sales and other near-term problems are being offset by Apple's incredible services business. If anything, this makes Apple quite a safe bet.
Cisco Systems is scheduled to release its fiscal third-quarter financial results after the markets close on Wednesday. Will it beat low expectations?
COVID-19 has already beaten up tobacco giant Altria but things may be getting even worse as Juul, in which it has a stake, is facing fresh problems.
Novavax shares jumped on Tuesday after the company announced that it would be receiving a sizable investment to further produce its COVID-19 vaccine.
CymaBay Therapeutics shares more than doubled on Tuesday after the company announced its first-quarter results, along with a corporate update.